These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16278981)

  • 61. Retrospective review of metformin in inpatients and outpatients at the University of Michigan.
    Sharabash HM; Remington TL; Mar P; Winston R; Walker PC
    Diabetes Care; 2006 Jan; 29(1):170-1. PubMed ID: 16373921
    [No Abstract]   [Full Text] [Related]  

  • 62. Metformin-induced hepatotoxicity.
    Miralles-Linares F; Puerta-Fernandez S; Bernal-Lopez MR; Tinahones FJ; Andrade RJ; Gomez-Huelgas R
    Diabetes Care; 2012 Mar; 35(3):e21. PubMed ID: 22355024
    [No Abstract]   [Full Text] [Related]  

  • 63. [Metformin: the overlap of diabetology and oncology].
    Anděl M; Skrha P; Trnka J
    Vnitr Lek; 2013 Aug; 59(8):738-42. PubMed ID: 24007233
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Metformin and reduced risk of cancer in diabetic patients.
    Evans JM; Donnelly LA; Emslie-Smith AM; Alessi DR; Morris AD
    BMJ; 2005 Jun; 330(7503):1304-5. PubMed ID: 15849206
    [No Abstract]   [Full Text] [Related]  

  • 65. Use of metformin is associated with lower incidence of cancer in patients with type 2 diabetes.
    Muszyńska-Ogłaza A; Zarzycka-Lindner G; Olejniczak H; Polaszewska-Muszyńska M; Junik R
    Endokrynol Pol; 2017; 68(6):652-658. PubMed ID: 29022647
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Changes in labelling for metformin use in patients with type 2 diabetes and heart failure: documented safety outweighs theoretical risks.
    Eurich DT; Majumdar SR; McAlister FA; Tsuyuki RT; Johnson JA
    Open Med; 2011; 5(1):e33-4. PubMed ID: 22046218
    [No Abstract]   [Full Text] [Related]  

  • 67. Metformin therapy and its anti-neoplastic role in systemic malignancies besides hepatocellular carcinomas.
    Kapoor S
    Scand J Gastroenterol; 2013 May; 48(5):636-7. PubMed ID: 23477305
    [No Abstract]   [Full Text] [Related]  

  • 68. Metformin and Pancreatic Cancer Risk in Patients With Type 2 Diabetes.
    Tseng CH
    Pancreas; 2018 Oct; 47(9):e57-e59. PubMed ID: 30199488
    [No Abstract]   [Full Text] [Related]  

  • 69. Metformin for cancer prevention.
    Yang Y
    Front Med; 2011 Jun; 5(2):115-7. PubMed ID: 21695613
    [No Abstract]   [Full Text] [Related]  

  • 70. Links among type 2 diabetes, cancer and metformin use: what have we learned?
    Sheen YJ; Sheu WH
    Diabetes Res Clin Pract; 2012 Aug; 97(2):169-71. PubMed ID: 22497968
    [No Abstract]   [Full Text] [Related]  

  • 71. Metformin and cancer: new applications for an old drug.
    Kourelis TV; Siegel RD
    Med Oncol; 2012 Jun; 29(2):1314-27. PubMed ID: 21301998
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Metformin and blood cancers.
    Cunha Júnior AD; Pericole FV; Carvalheira JBC
    Clinics (Sao Paulo); 2018 Sep; 73(suppl 1):e412s. PubMed ID: 30208162
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation.
    Farmer RE; Ford D; Forbes HJ; Chaturvedi N; Kaplan R; Smeeth L; Bhaskaran K
    Int J Epidemiol; 2017 Apr; 46(2):728-744. PubMed ID: 28031313
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Metformin, cancer, alphabet soup, and the role of epidemiology in etiologic research.
    Duncan BB; Schmidt MI
    Diabetes Care; 2009 Sep; 32(9):1748-50. PubMed ID: 19717820
    [No Abstract]   [Full Text] [Related]  

  • 75. [Not Available].
    Müller T
    MMW Fortschr Med; 2024 Jun; 166(10):11. PubMed ID: 38806900
    [No Abstract]   [Full Text] [Related]  

  • 76. Commentary: metformin use is associated with reduced gastric cancer risk.
    de Vries AC; Kuipers EJ
    Aliment Pharmacol Ther; 2014 May; 39(10):1239. PubMed ID: 24735141
    [No Abstract]   [Full Text] [Related]  

  • 77. Does long-term metformin usage reduce gastric cancer risk?
    Coban S
    Turk J Gastroenterol; 2014 Feb; 25(1):125. PubMed ID: 24918151
    [No Abstract]   [Full Text] [Related]  

  • 78. Commentary: metformin use is associated with reduced gastric cancer risk - authors' reply.
    Kim YI; Cho SJ
    Aliment Pharmacol Ther; 2014 May; 39(10):1239-40. PubMed ID: 24735142
    [No Abstract]   [Full Text] [Related]  

  • 79. Repurposing metformin for the prevention of cancer and cancer recurrence.
    Heckman-Stoddard BM; DeCensi A; Sahasrabuddhe VV; Ford LG
    Diabetologia; 2017 Sep; 60(9):1639-1647. PubMed ID: 28776080
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Diabetes mellitus, medications for type 2 diabetes mellitus, and cancer risk.
    La Vecchia C
    Metabolism; 2011 Oct; 60(10):1357-8. PubMed ID: 21550082
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.